Next-Generation Sequencing-Based Analysis of HLA Variants in Turkish Patients with Obstructive Sleep Apnea

This prospective case-control study utilized high-resolution Next-Generation Sequencing to identify specific HLA alleles (A*02:01, C*03:03:01, C*14:03, and DRB1*04:05) as predisposing factors and others (A*03:01 and B*35:02) as protective markers for obstructive sleep apnea in a Turkish population.

The Gist

Imagine your body is a bustling city. Inside this city, there is a specialized security force called the Immune System. Its job is to patrol the streets, looking for troublemakers like viruses or bacteria, while ignoring the innocent citizens (your own cells).

To do this job, the security force relies on a massive, highly detailed ID card system called the HLA (Human Leukocyte Antigen). Think of these ID cards as unique barcodes on every cell in your body. If a cell's barcode matches the "master list," the security force leaves it alone. If the barcode looks weird or foreign, the security force attacks.

The Problem: Obstructive Sleep Apnea (OSA)
Now, imagine a traffic jam in this city, but instead of cars, it's your airway. In people with Obstructive Sleep Apnea (OSA), the throat muscles relax too much during sleep, causing the airway to collapse. It's like a tunnel getting blocked, stopping air from flowing. This makes the person stop breathing for a few seconds, wake up gasping, and never get a good night's rest.

We know that being overweight or having a certain face shape can cause this traffic jam. But scientists have long suspected that genetics (your family's blueprint) also plays a huge role. Why do some people with similar body types get OSA, while others don't?

The Old Way vs. The New Way
For decades, scientists tried to find the genetic "smoking gun" by looking at these HLA ID cards. But they were using old, blurry cameras (serological tests). It was like trying to read a license plate from a mile away in the fog. They could see the general shape of the car, but they couldn't read the specific numbers. This led to confusing and inconsistent results.

The New Investigation
In this new study, researchers in Turkey decided to upgrade their equipment. They used Next-Generation Sequencing (NGS).

• The Analogy: If the old method was looking at a license plate through foggy glasses, the new method is like using a high-definition drone camera that zooms in so close you can read every single letter and number on the plate, even the tiny scratches.

They took 100 people:

1. 50 People with OSA: The "traffic jam" group.
2. 50 Healthy People: The "smooth traffic" group.

They scanned the "ID cards" (HLA genes) of everyone with their high-definition drone camera to see if specific barcode patterns were more common in the "traffic jam" group.

The Big Discoveries
The high-resolution scan revealed some very specific patterns:

• The "Risk" Barcodes: The researchers found that people with OSA were much more likely to have specific versions of the ID cards: HLA-A*02:01, HLA-C*03:03:01, HLA-C*14:03, and HLA-DRB1*04:05.

  • Think of this like finding that most people stuck in the traffic jam have a specific type of red hat. It doesn't mean the hat causes the jam, but if you see someone wearing that red hat, they are statistically more likely to be part of the problem. These are "predisposing" markers.

• The "Protective" Barcodes: Conversely, the healthy people (the smooth traffic group) had a lot more of two other specific ID cards: HLA-A*03:01 and HLA-B*35:02.

  • Think of this like finding that the people who never get stuck in traffic almost always wear a blue helmet. It suggests these specific genetic codes might act as a shield, protecting people from developing the condition.

Why This Matters

1. Precision: Because they used the "drone camera" (NGS), they didn't just find a general "red hat" (like HLA-A2); they found the exact model (HLA-A*02:01). Previous studies using blurry cameras missed these details.
2. New Clues: They found connections in the "C" and "DRB1" sections of the ID card that no one had noticed before in Turkish patients.
3. Future Hope: While this study is just the beginning (it's a small group of 100 people), it proves that our immune system's "ID card system" is deeply linked to sleep apnea.

The Bottom Line
This study is like upgrading from a sketch to a high-definition photograph. It tells us that for Turkish people, specific genetic "barcodes" make you more likely to have sleep apnea, while others might protect you. In the future, doctors might be able to look at your genetic ID card and say, "Hey, you have these specific markers; you should be extra careful about your sleep health," potentially catching the problem before it even starts.

Technical Summary

1. Problem Statement

Obstructive Sleep Apnea (OSA) is a prevalent respiratory disorder characterized by upper airway collapse during sleep. While its pathogenesis involves anatomical and neuromuscular factors, the genetic architecture remains partially understood. Previous research has suggested a link between the Human Leukocyte Antigen (HLA) system and OSA, given the HLA system's role in immune regulation and inflammation. However, prior studies suffered from significant limitations:

• Low Resolution: Most previous studies relied on serological methods or low-resolution PCR techniques (SSO/SSP), which could only identify alleles at the two-digit level (e.g., HLA-A2) and often yielded inconsistent results.
• Ambiguity: Serological methods cannot distinguish between distinct DNA sequences that encode proteins with identical reactivity.
• Population Gaps: Existing data on Turkish populations is limited and lacks high-resolution genomic mapping.
• Confounding Factors: Earlier studies often failed to control for confounding variables like Body Mass Index (BMI) or used small, unbalanced cohorts.

The study aims to overcome these limitations by utilizing high-resolution Next-Generation Sequencing (NGS) to identify specific HLA alleles associated with OSA susceptibility or protection in a Turkish cohort.

2. Methodology

Study Design:

• Type: Prospective case-control study.
• Location: Necmettin Erbakan University, Konya, Turkey.
• Participants: 100 total participants (50 newly diagnosed OSA patients and 50 healthy controls).
  • Cases: Diagnosed via comprehensive overnight polysomnography (PSG) with an Apnea-Hypopnea Index (AHI) ≥ 5.
  • Controls: Healthy volunteers with low clinical risk for OSA, normal sleep patterns, and low Epworth Sleepiness Scale (ESS) scores.
• Exclusion Criteria: Patients with other sleep disorders (e.g., narcolepsy, central sleep apnea), severe pulmonary diseases, or comorbidities like Cushing's syndrome were excluded.

Genotyping Protocol:

• Technology: Targeted Next-Generation Sequencing (NGS) using the Illumina MiniSeq platform.
• Kit: MIA FORA NGS FLEX HLA Typing Kit (Immucor Inc.).
• Loci Analyzed: High-resolution typing (4 to 6-digit resolution) was performed for HLA-A, -B, -C, -DQB1, and -DRB1.
• Coverage: The sequencing covered all exons and introns for Class I and Class II genes, including specific untranslated regions (UTRs), ensuring comprehensive allele detection.
• Data Analysis: Sequencing data was analyzed using MIA FORA NGS FLEX software (v3.0) against the IPD-IMGT/HLA database. Allele identification focused on coding sequence variations.

Statistical Analysis:

• Allele frequencies were compared between groups using Chi-square ($\chi^2$) or Fisher's exact tests.
• Odds Ratios (OR) and 95% Confidence Intervals (CI) were calculated.
• Significance threshold: $p < 0.05$.

3. Key Contributions

• Technological Advancement: This is the first study to investigate the HLA-OSA relationship using high-resolution NGS in the Turkish population, moving beyond the limitations of serological and low-resolution PCR methods used in previous decades.
• Granular Resolution: By distinguishing specific subtypes (e.g., differentiating HLA-A02:01 from other HLA-A02 variants), the study provides a level of precision previously unattainable in OSA genetics.
• Population Specificity: It provides the first comprehensive HLA map for OSA specifically within the Turkish demographic, addressing the lack of data for this ethnic group.
• Novel Markers: The study identifies specific alleles that were previously unreported in the context of OSA, refining the understanding of genetic susceptibility.

4. Key Results

The study identified statistically significant associations between specific HLA alleles and OSA status:

Predisposing Alleles (Higher frequency in OSA patients):

• HLA-A*02:01: $p = 0.036$
• HLA-C*03:03:01: $p = 0.007$
• HLA-C*14:03: $p = 0.043$
• HLA-DRB1*04:05: $p = 0.013$

Protective Alleles (Higher frequency in healthy controls):

• HLA-A*03:01: $p = 0.024$
• HLA-B*35:02: $p = 0.043$

Notable Findings:

• HLA-B*44:03: Showed a borderline significance ($p = 0.054$), suggesting a potential role that warrants further investigation in larger cohorts.
• HLA-DQB1: No statistically significant associations were found in this locus, contrasting with some international studies that linked DQB1*06:02 to OSA. This highlights ethnic heterogeneity in genetic risk factors.
• Demographics: There were no significant differences in age, gender, or BMI between the patient and control groups, strengthening the validity of the genetic associations by minimizing confounding by obesity.

5. Significance and Conclusion

• Immunogenetic Basis: The findings reinforce the hypothesis that OSA has an immunogenetic component, likely mediated through inflammatory pathways regulated by the HLA system.
• Precision Medicine: The identification of specific predisposing (e.g., HLA-DRB104:05) and protective (e.g., HLA-A03:01) alleles could eventually facilitate genetic screening to identify high-risk individuals before clinical symptoms manifest.
• Methodological Superiority: The study demonstrates that NGS is essential for resolving complex HLA associations. Previous studies using serology may have missed these specific associations or mischaracterized them due to low resolution.
• Future Directions: While the sample size (n=100) is a limitation, the study provides a foundational genetic profile. The authors call for large-scale, multi-center studies to validate these findings and explore the functional mechanisms by which these specific alleles influence upper airway collapse and sleep architecture.

In summary, this paper establishes a high-resolution genetic map for OSA in Turkish patients, identifying novel risk and protective HLA alleles that were previously undetectable with older methodologies.